These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 36950907)

  • 1. Fully integrated downstream process to enable next-generation manufacturing.
    Ramos I; Sharda N; Villafana R; Hill-Byrne K; Cai K; Pezzini J; Coffman J
    Biotechnol Bioeng; 2023 Jul; 120(7):1869-1881. PubMed ID: 36950907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A modular and multi-functional purification strategy that enables a common framework for manufacturing scale integrated and continuous biomanufacturing.
    Pybus LP; Heise C; Nagy T; Heeran C; Dover T; Raven J; Kori J; Burton G; Sakuyama H; Hastings B; Lyons M; Nakai S; Haigh J
    Biotechnol Prog; 2024; 40(4):e3456. PubMed ID: 38494903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Process-wide control and automation of an integrated continuous manufacturing platform for antibodies.
    Feidl F; Vogg S; Wolf M; Podobnik M; Ruggeri C; Ulmer N; Wälchli R; Souquet J; Broly H; Butté A; Morbidelli M
    Biotechnol Bioeng; 2020 May; 117(5):1367-1380. PubMed ID: 32022243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Process design of a fully integrated continuous biopharmaceutical process using economic and ecological impact assessment.
    Ding C; Ardeshna H; Gillespie C; Ierapetritou M
    Biotechnol Bioeng; 2022 Dec; 119(12):3567-3583. PubMed ID: 36109341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Throughput Optimization of Continuous Biopharmaceutical Manufacturing Facilities.
    Garcia FA; Vandiver MW
    PDA J Pharm Sci Technol; 2017; 71(3):189-205. PubMed ID: 27974629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfer of continuous manufacturing process principles for mAb production in a GMP environment: A step in the transition from batch to continuous.
    Botelho Ferreira K; Benlegrimet A; Diane G; Pasquier V; Guillot R; De Poli M; Chappuis L; Vishwanathan N; Souquet J; Broly H; Bielser JM
    Biotechnol Prog; 2022 Jul; 38(4):e3259. PubMed ID: 35412696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GMP implementation of a hybrid continuous manufacturing process for a recombinant non-mAb protein-A case study.
    Natarajan V; Soice N; Mullen J; Bull D
    Biotechnol Prog; 2024; 40(4):e3459. PubMed ID: 38553839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling the Downstream Processing of Monoclonal Antibodies Reveals Cost Advantages for Continuous Methods for a Broad Range of Manufacturing Scales.
    Hummel J; Pagkaliwangan M; Gjoka X; Davidovits T; Stock R; Ransohoff T; Gantier R; Schofield M
    Biotechnol J; 2019 Feb; 14(2):e1700665. PubMed ID: 29341493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Current Scientific and Regulatory Landscape in Advancing Integrated Continuous Biopharmaceutical Manufacturing.
    Fisher AC; Kamga MH; Agarabi C; Brorson K; Lee SL; Yoon S
    Trends Biotechnol; 2019 Mar; 37(3):253-267. PubMed ID: 30241924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated continuous biomanufacturing on pilot scale for acid-sensitive monoclonal antibodies.
    Schwarz H; Gomis-Fons J; Isaksson M; Scheffel J; Andersson N; Andersson A; Castan A; Solbrand A; Hober S; Nilsson B; Chotteau V
    Biotechnol Bioeng; 2022 Aug; 119(8):2152-2166. PubMed ID: 35470430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The design basis for the integrated and continuous biomanufacturing framework.
    Coffman J; Bibbo K; Brower M; Forbes R; Guros N; Horowski B; Lu R; Mahajan R; Patil U; Rose S; Shultz J
    Biotechnol Bioeng; 2021 Sep; 118(9):3323-3333. PubMed ID: 33522595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enablers of continuous processing of biotherapeutic products.
    Rathore AS; Zydney AL; Anupa A; Nikita S; Gangwar N
    Trends Biotechnol; 2022 Jul; 40(7):804-815. PubMed ID: 35034769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Converting a mAb downstream process from batch to continuous using process modeling and process analytical technology.
    Chen R; Chen XJ; Shi C; Jiao B; Shi Y; Yao B; Lin DQ; Gong W; Hsu S
    Biotechnol J; 2022 Nov; 17(11):e2100351. PubMed ID: 35908168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot-scale demonstration of an end-to-end integrated and continuous biomanufacturing process.
    Coolbaugh MJ; Varner CT; Vetter TA; Davenport EK; Bouchard B; Fiadeiro M; Tugcu N; Walther J; Patil R; Brower K
    Biotechnol Bioeng; 2021 Sep; 118(9):3287-3301. PubMed ID: 33410159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
    J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current challenges and recent advances on the path towards continuous biomanufacturing.
    Drobnjakovic M; Hart R; Kulvatunyou BS; Ivezic N; Srinivasan V
    Biotechnol Prog; 2023; 39(6):e3378. PubMed ID: 37493037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-line product quality monitoring during biopharmaceutical manufacturing using computational Raman spectroscopy.
    Wang J; Chen J; Studts J; Wang G
    MAbs; 2023; 15(1):2220149. PubMed ID: 37288839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomanufacturing evolution from conventional to intensified processes for productivity improvement: a case study.
    Xu J; Xu X; Huang C; Angelo J; Oliveira CL; Xu M; Xu X; Temel D; Ding J; Ghose S; Borys MC; Li ZJ
    MAbs; 2020 Jan; 12(1):1770669. PubMed ID: 32425110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. End-to-end collaboration to transform biopharmaceutical development and manufacturing.
    Erickson J; Baker J; Barrett S; Brady C; Brower M; Carbonell R; Charlebois T; Coffman J; Connell-Crowley L; Coolbaugh M; Fallon E; Garr E; Gillespie C; Hart R; Haug A; Nyberg G; Phillips M; Pollard D; Qadan M; Ramos I; Rogers K; Schaefer G; Walther J; Lee K
    Biotechnol Bioeng; 2021 Sep; 118(9):3302-3312. PubMed ID: 33480041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developments and opportunities in continuous biopharmaceutical manufacturing.
    Khanal O; Lenhoff AM
    MAbs; 2021; 13(1):1903664. PubMed ID: 33843449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.